What Appendix Cancer Patients Need to Know…
I was surprised when this showed up in my “Google Alerts” for Appendiceal Cancer this morning. I was just talking with someone who had a positive Signatera result about this very subject two weeks ago. It was a low score, but tumor DNA was detected. He went in for CT Scans the next week and they were clean.
A recent multi-center study scanned 327 healthy adults for early signs of cancer. Here is what it found and what it means in appendix cancer. You can access the original study here: Whole-body magnetic resonance imaging for cancer screening in asymptomatic adults: a multicenter study
If you have been touched by appendix cancer, you already understand something most people do not. Cancer can grow quietly. It can exist without symptoms. And by the time it is found, it can already be advanced.
So when you hear about something called a whole body MRI for cancer screening, a natural question follows: could this help find cancer earlier?
A study published in March 2026 in the European Journal of Cancer Prevention tried to answer that. Here is what it found, and what it means for this community.
What is a whole body MRI?
A whole body MRI is a scan that evaluates your entire body in a single session. Unlike CT scans, it does not use ionizing radiation. Instead, it uses magnetic fields to create detailed images of your organs and tissues.
Doctors originally used this type of scan to monitor patients who already had cancer. More recently, it has been explored as a way to look for cancer in people who feel completely healthy….before any symptoms appear.
What did this study do?
Researchers at four diagnostic centers in Italy enrolled 327 adults who had no symptoms and no known cancer diagnosis. All of them voluntarily chose to undergo whole body MRI as part of a private preventive screening program. The median age was 52.
Each scan was read by a team of subspecialist radiologists. One focused on the brain and spine, one on the chest, abdomen, and pelvis, and one on bones and soft tissue. Findings were classified using a standardized system called ONCO-RADS, which ranks results from 1 (normal) to 5 (highly suspicious for malignancy).
What did the scans find?
42.2 percent of participants (138 out of 327) had at least one finding classified as ONCO-RADS 3 or higher, meaning it warranted follow-up or monitoring.
The overwhelming majority of those flagged findings were ONCO-RADS 3 (97.9%), which the system defines as likely benign. These are findings that need monitoring but are not expected to be malignant.
Three people out of 327 were ultimately diagnosed with cancer – a detection rate of just under 1 percent.
One of those three confirmed cancers was appendiceal carcinoma.
The other two were prostate cancer and renal cell carcinoma, both caught in people with no symptoms.
| Two truths sitting side by side These scans can find cancer before symptoms appear. In this study, three malignancies were detected in people who felt completely fine. For rare cancers that are often discovered late, including appendiceal cancer. That is not a small thing. At the same time, these scans generate a substantial number of findings that are not cancer, but cannot simply be dismissed. The majority of flagged results in this study were in the “likely benign” category, but likely benign still means more imaging, more follow-up appointments, and more time spent in uncertainty. |
Why this matters for appendix cancer patients
Appendix cancer is rare and often found by accident….during a routine appendectomy or incidentally on imaging done for something else entirely. That diagnostic reality has led many patients and caregivers to pay close attention to tools that scan the whole body at once.
But the evidence base for whole body MRI as a routine screening tool is still developing. As of now:
- Whole body MRI is not a standard cancer screening recommendation for the general population
- There are no clinical guidelines directing most people to seek this type of scan
- Its role in higher-risk groups, including people with hereditary cancer syndromes, is still being studied and refined
For people with a personal or family history of appendix cancer, the question of whether whole body MRI makes sense is one worth raising with a physician who knows your specific history and risk profile. It is not a simple yes or no.
A note on the technology piece
This study had a second aim that is less clinically dramatic but worth understanding. The researchers tested whether an artificial intelligence tool could accurately pull structured information out of free-text radiology reports….essentially automating the work of organizing findings from dozens of different report styles across four centers.
The AI performed well overall, correctly extracting 87.3 percent of the relevant findings. But it missed about 7 percent and made anatomical localization errors in another 5.5 percent of cases.
The point is not that AI tools cannot help….they clearly can, at scale. The point is that they are not yet a substitute for expert clinical review, and the researchers were careful to say so. AI was used to organize information that radiologists had already documented. It did not diagnose anything on its own.
That distinction matters as these tools become more widely discussed in patient communities.
Questions to Ask Your Doctor
- Is whole body MRI something I should consider given my personal or family history?
- What are the realistic chances that a scan like this would find something actionable for someone with my risk profile?
- If a scan identified an “indeterminate” finding, what would the follow-up process look like and what is the emotional and logistical cost of that?
- Are there more targeted imaging approaches that make more sense for my situation?
At Appendicure, we will keep tracking the research that matters for this community. If you have questions about your diagnosis or want help finding a specialist, sign up for our website or join our private Facebook at https://www.facebook.com/groups/appendicure.
Source: Ali M et al., “Whole-body magnetic resonance imaging for cancer screening in asymptomatic adults: a multicenter study.” European Journal of Cancer Prevention, March 2026. doi:10.1097/CEJ.0000000000001015

Leave a Reply